Search

everythinglearnresearchcommunity

for

Search:↓

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Deucravacitinib helped a man regrow hair significantly.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Apremilast showed mixed results for treating severe alopecia areata.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Apremilast may help treat hair loss in alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Methotrexate is not proven to maintain remission in ulcerative colitis.

A new therapy for a skin blistering condition has not been developed yet.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Apremilast improved symptoms in patients with severe skin conditions.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

ISX9 helps regrow hair by activating a specific cell signaling pathway.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.